53 citations
,
November 2006 in “Journal of Endocrinology”
This study found that prolactin plays a direct role in regulating the timing of hair growth cycles in mice by affecting the skin, rather than through other endocrine factors.
6 citations
,
August 2007 in “Journal of Surgical Research”
In this study, constitutive expression of Del1 in mice did not affect wound healing but was associated with increased hair growth following anagen induction.
This study developed a micellar electrokinetic capillary chromatography method for determining minoxidil in Rogaine and generic products, offering a simple and efficient alternative to HPLC.
4 citations
,
May 2022 in “International journal of molecular sciences”
This study found that heat-killed Enterococcus faecalis EF-2001 promoted hairregrowth in mice, likely by increasing the expression of growth factors and marker genes.
Bhringraj oil showed better hairregrowth results than minoxidil in mice, but its effectiveness in humans is uncertain. Users discussed using bhringraj oil, coconut oil, and microneedling for hairregrowth, with some reporting slow but noticeable improvements.
Hairregrowth treatments are effective in mice but not yet available for humans. The discussion humorously highlights frustration over this disparity and mentions a project to genetically modify elephants to resemble mammoths.
Hairregrowth on wounded and bald skin may be possible by activating the sonic hedgehog gene, leading to hairregrowth in mice. The findings are promising but may not directly apply to humans.
Adipose-derived stem cells with ATP improved hairregrowth in male and female mice with androgenetic alopecia. The most effective treatments were low dose stem cells with ATP for males and medium dose stem cells with non-liposomal ATP for females.
A serum with oleic and palmitoleic acids shows promise for hairregrowth in mice, but its effectiveness in humans is unproven. Minoxidil and finasteride remain the recommended treatments.
Prostaglandin eye drop used for glaucoma and eyelash growth
How does bimatoprost compare to minoxidil for hairregrowth?Minoxidil is FDA-approved for scalp hair loss and backed by decades of large trials; bimatoprost is approved only for eyelashes, and the published scalp evidence is limited to small short studies, so on the scalp it is off-label and experimental.
Is latanoprost more effective for hairregrowth than minoxidil?No trial has compared latanoprost and minoxidil head to head. Minoxidil has large randomized trials and FDA approval for hair loss, while latanoprost's scalp evidence is a single 24-week pilot in 16 men, so the published evidence does not support latanoprost being the more effective option.
What do clinical trials say about the safety and effectiveness of SCUBE3 for hairregrowth?No clinical trial of SCUBE3 for hair regrowth has been registered on ClinicalTrials.gov or published, so there is no human safety or effectiveness data. The evidence is limited to one 2022 laboratory and mouse study reporting that SCUBE3 activates hair follicle stem cells through TGF-beta signalling.